CPHA Canvax
CPHA Canvax

Seasonal Influenza 2020-2021 Recommendations in the Context of COVID-19

Organization: National Collaborating Centre for Infectious Diseases (NCCID)
 Published: 2020
Bookmark

"Learn about this year’s recommendations for the prevention and treatment of seasonal influenza, the use of antivirals, the recommended vaccinations, and infection and prevention control measures to reduce the risk of COVID-19 transmission at the time of flu vaccine administration." - Seasonal Influenza 2020-2021 Recommendations in the Context of COVID-19

For additional information and presenter slides, visit the link below.  

Seasonal Influenza 2020-2021 Recommendations in the Context of COVID-19
Author(s): Ian Gemmill, Robyn Harrison , Gerald Evans Rating See Comments Ratings
Resource Group: Background Knowledge
 Product Type: Webinar

Category:

Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Preventable Diseases,Communicable Diseases,Influenza Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Influenza
Audience: Health Care Professional
 Population: Adults
Children (All)
Pregnant and Breastfeeding People
Seniors
 Region: National
Language: English
Link

Addendum to the guidance on the use of COVID-19 vaccines in the fall of 2023

Organization: Public Health Agency of Canada (PHAC) Published: 2023
Link

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Organization: United States Centers for Disease Control (CDC) Published: 2023
Link

Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations

Organization: United States Centers for Disease Control (CDC) Published: 2023

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.

Login or register to comment